Physician profile
Yan Li
NPI 1346640604
$1,060.07
in general payments reported to CMS, 2019-2025
12 companies · $170 in 2025
The $170 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.09 · 2020: $40.34 · 2021: $123 · 2022: $360 · 2023: $149 · 2024: $143 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $461.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $255.03 | 2021-2024 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.88 | 2022-2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $161.37 | 2021-2023 | Xarelto |
| Genzyme Corporation | $146.16 | 2025 | |
| Novartis Pharmaceuticals Corporation | $88.69 | 2022-2023 | |
| Lilly USA, LLC | $67.68 | 2020-2022 | |
| Gilead Sciences, INC. | $60.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $40.69 | 2022 | |
| Astellas Pharma US INC | $23.77 | 2025 | Cresemba |
| Ucb, INC. | $19.54 | 2020 | |
| Pfizer INC. | $15.09 | 2019 | |
| Scpharmaceuticals INC. | $13.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yan Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.